natgillin/translations-raw huggingface dataset:
Bolus (meal-time) insulin requirements: NovoRapid will start to lower your blood sugar within 1020 minutes after you start a bolus delivery (see section 3, How to use NovoRapid PumpCart, for more information about how to adjust your bolus dose). 
Bolusne potrebe po insulinu (potrebe ob obrokih): Zdravilo NovoRapid vam bo začelo zniževati krvni sladkor v 10 do 20 minutah po začetku bolusnega dajanja (za več informacij o prilagajanju bolusnega odmerka glejte poglavje 3, Kako uporabljati zdravilo NovoRapid PumpCart).
If your blood sugar is low or high, your concentration and ability to react might be affected and therefore also your ability to drive or operate a machine. Bear in mind that you could endanger yourself or others. 
Če imate visok ali nizek krvni sladkor, se vam zbranost in sposobnost reagiranja lahko spremenita, s tem pa tudi vaša sposobnost za upravljanje vozil in strojev.
► If you have such a low blood sugar that it makes you pass out, if you have had need for injection of glucagon, or if you have experienced many incidents of low blood sugar, talk with a doctor. 
► Če imate tako nizek krvni sladkor, da se onesvestite, če ste morali dobiti injekcijo glukagona ali če ste velikokrat imeli nizek krvni sladkor, se posvetujte z zdravnikom.
The insulin will work more quickly if injected into the front of your waist. 
Insulin bo začel delovati hitreje, če si ga injicirate v sprednji del trebuha.
Your bolus (meal-time) insulin needs to be adjusted based on your blood sugar measurement and food intake. 
Bolusne odmerke insulina (odmerke ob obrokih) morate prilagoditi glede na izmerjeni krvni sladkor in uživanje hrane.
► Keep the needle under your skin for at least 6 seconds to make sure you have injected all the insulin. 
► Igla naj ostane pod kožo vsaj 6 sekund; tako boste zagotovili injiciranje vsega insulina.
b) List of other side effects 
b) Seznam drugih neželenih učinkov
Octreotide/lanreotide may either increase or decrease the insulin requirement. 
Oktreotid/lanreotid lahko potrebo po insulinu zveča ali zmanjša.
The absorption rate was somewhat slower in type 2 diabetic patients, resulting in a lower Cmax (352±240 pmol/l) and later tmax (60 (interquartile range: 50-90) minutes). 
Pri bolnikih s sladkorno boleznijo tipa 2 je bila hitrost absorpcije nekoliko počasnejša, zato je bila Cmax manjša (352 ± 240 pmol/l), tmax pa poznejši (60 (interkvartilni razpon: 50-90) minut).
Use the injection technique advised by your doctor or nurse and as described in your pen manual. 
Za injiciranje uporabite postopek, ki vam ga je svetoval zdravnik ali medicinska sestra in kot je opisan v priročniku vašega injekcijskega peresnika.
METHOD AND ROUTES OF ADMINISTRATION Needles are not included 
POSTOPEK IN POTI UPORABE ZDRAVILA Igle niso priložene.
NovoRapid may be used in an infusion pump system (CSII) as described in section 4.2. 
Zdravilo NovoRapid se lahko uporablja v infuzijskem sistemu s črpalko (CSII), kot je opisano v poglavju 4.2.
High blood sugar (hyperglycaemia) 
Visok krvni sladkor (hiperglikemija)
NovoRapid must be protected from excessive heat and light. 
Zdravilo NovoRapid je treba zaščititi pred čezmerno toploto in svetlobo.
• Dispose of the empty NovoRapid PumpCart cartridge and the used infusion set as instructed by your doctor or nurse. 
• Zavrzite prazni vložek NovoRapid PumpCart ter uporabljeni komplet za infundiranje, kot vam je naročil zdravnik ali medicinska sestra.
You can carry it with you and keep it at room temperature (below 30°C) for up to 4 weeks. 
S seboj ga lahko nosite in shranjujete pri sobni temperaturi (do 30 °C) do 4 tedne.
If you experience any problems contact your doctor. 
Če se vam pojavijo kakšne težave, se posvetujte z zdravnikom.
Patients whose blood glucose control is greatly improved, e.g. by intensified insulin therapy, may experience a change in their usual warning symptoms of hypoglycaemia, and should be advised accordingly. 
Bolnikom, ki se jim uravnanost glukoze v krvi zelo izboljša, npr. z intenziviranim insulinskim zdravljenjem, se običajni opozorilni simptomi hipoglikemije lahko spremenijo in jih je s to možnostjo treba seznaniti.
NovoRapid will start to lower your blood sugar 10-20 minutes after you inject it, a maximum effect occurs between 1 and 3 hours after the injection and the effect lasts for 3-5 hours. 
Zdravilo NovoRapid začne sladkor v krvi zniževati v 10 do 20 minutah po uporabi, doseže največji učinek v 1 do 3 urah po injiciranju in deluje od 3 do 5 ur.
Compared to soluble human insulin the faster onset of action of NovoRapid is maintained regardless of the injection site. 
V primerjavi s topnim humanim insulinom se hitrejši začetek delovanja zdravila NovoRapid ohrani ne glede na mesto injiciranja.
The maximum effect occurs between 1 and 3 hours after the bolus delivery and the effect lasts for 3 to 5 hours. 
Največji učinek se pojavi od 1 do 3 ure po bolusnem dajanju, učinek pa traja od 3 do 5 ur.
In case of hypoglycaemia or if hypoglycaemia is suspected NovoRapid must not be injected. 
V primeru hipoglikemije ali suma na hipoglikemijo se zdravila NovoRapid ne sme injicirati.
When you change the infusion set (tubing and needle), be sure to change the site for inserting the needle (injection site). 
Ko menjate komplet za infundiranje (cevko in iglo), ne pozabite zamenjati mesta, kamor vstavite iglo (mesto injiciranja).
When necessary, you can take the bolus dose just after you have finished eating. 
Če je treba, lahko bolusni odmerek uporabite takoj potem, ko ste pojedli.
NovoRapid produces a more rapid onset of action compared to soluble human insulin, together with a lower glucose concentration, as assessed within the first four hours after a meal. 
Zdravilo NovoRapid začne v primerjavi s topnim humanim insulinom delovati hitreje in povzroči, da je koncentracija glukoze, merjena v prvih štirih urah po obroku, nižja.
The following substances may increase the patient's insulin requirements: Oral contraceptives, thiazides, glucocorticoids, thyroid hormones, sympathomimetics, growth hormone and danazol. 
Bolnikovo potrebo po insulinu lahko zvečajo naslednje snovi: peroralni kontraceptivi, tiazidi, glukokortikoidi, ščitnični hormoni, simpatikomimetiki, rastni hormon in danazol.
• Angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure) 
• zaviralce angiotenzinske konvertaze (ACE - angiotensin converting enzyme) (uporabljajo se za zdravljenje določenih bolezenskih stanj srca ali visokega krvnega tlaka),
J Insert the needle into your skin as your doctor or nurse has shown you. 
J Iglo zabodite v kožo tako, kot sta vam pokazala zdravnik ali medicinska sestra.
Before you use NovoRapid PumpCart in the pump you must have received a comprehensive instruction by your doctor or nurse. 
Pred uporabo zdravila NovoRapid PumpCart v črpalki morate opraviti izčrpno usposabljanje, ki vam ga bo zagotovil zdravnik ali medicinska sestra.
Changing the site with each injection reduces the risk of developing such skin changes. 
Menjavanje mesta injiciranja pri vsaki injekciji zmanjša tveganje za nastanek takšnih kožnih sprememb.
Always make sure that a drop appears at the needle tip before you inject. 
Vedno se prepričajte, da se na konici igle pojavi kapljica, preden injicirate vaš odmerek.
See How and where to inject below for information. 
Za informacije glejte podpoglavje Kako in kje injicirati v nadaljevanju.
It should normally be used in combination with intermediate-acting or long-acting insulin. 
Praviloma naj bi ga uporabljali v kombinaciji s srednjedolgodelujočim ali z dolgodelujočim insulinom.
EXP/ During use in pump: Use within 7 days 
EXP/ Med uporabo v insulinski črpalki: porabite v 7 dneh.
A mean maximum plasma concentration of 492±256 pmol/l was reached 40 (interquartile range: 30-40) minutes after a subcutaneous dose of 0.15 unit/kg bodyweight in type 1 diabetic patients. 
Povprečna največja koncentracija v plazmi 492 ± 256 pmol/l je bila pri bolnikih s sladkorno boleznijo tipa 1 dosežena v 40 (interkvartilni razpon: 30-40) minutah po subkutanem odmerku 0,15 enote/kg telesne mase.
Other medicines and NovoRapid 
Druga zdravila in zdravilo NovoRapid
In patients with hepatic impairment, absorption rate was decreased and more variable, resulting in delayed tmax from about 50 min in subjects with normal hepatic function to about 85 min in patients with moderate and severe hepatic impairment. 
Pri bolnikih z okvaro jeter je bila hitrost absorpcije nižja in bolj spremenljiva, zato je bil tmax daljši in se je gibal v razponu od 50 minut pri preiskovancih z normalnim delovanjem jeter do 85 minut pri bolnikih z zmerno in hudo okvaro jeter.
Data were limited in patients with moderate and severe renal impairment. 
Pri bolnikih z zmerno in hudo okvaro ledvic so bili podatki omejeni.
NovoRapid is generally taken immediately before a meal. 
Zdravilo NovoRapid se praviloma uporablja tik pred obrokom.
On rare occasions, injection site reactions may require discontinuation of NovoRapid. 
V redkih primerih je lahko zaradi reakcij na mestu injiciranja potrebna prekinitev zdravljenja z zdravilom NovoRapid.
Never inject directly into a vein (intravenously) or muscle (intramuscularly). 
Zdravila nikoli ne injicirajte neposredno v veno (intravensko) ali v mišico (intramuskularno).
Administration in a pump system will require a comprehensive instruction by your healthcare professional. 
Za uporabo v sistemu s črpalko boste potrebovali izčrpno usposabljanje, ki vam ga bo zagotovil vaš zdravnik.
A decreased absorption rate was observed in elderly patients, resulting in a later tmax (82 (interquartile range: 60-120) minutes), whereas Cmax was similar to that observed in younger patients with type 2 diabetes and slightly lower than in patients with type 1 diabetes. 
Pri starejših bolnikih je bila hitrost absorpcije nižja, zato je bil tmax daljši (82 (interkvartilni razpon: 60-120) minut), medtem ko je bila Cmax podobna kot pri mlajših bolnikih s sladkorno boleznijo tipa 2 in rahlo nižja kot pri bolnikih s sladkorno boleznijo tipa 1.
NovoRapid can be used during pregnancy. 
Zdravilo NovoRapid lahko uporabljate med nosečnostjo.
Uncommon side effects May affect less than 1 in 100 people. 
Občasni neželeni učinki Pojavijo se lahko pri manj kot 1 od 100 bolnikov.
NovoRapid is for injection under the skin (subcutaneously) or for continuous infusion in a pump system. 
Zdravilo NovoRapid je namenjeno injiciranju pod kožo (subkutani uporabi) ali za stalno infundiranje v sistemu s črpalko.
Omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycaemia. 
Hipoglikemija Izpustitev obroka ali nenačrtovana, naporna telesna dejavnost lahko povzročita hipoglikemijo.
A clinical trial comparing safety and efficacy of insulin aspart vs. human insulin in the treatment of pregnant women with type 1 diabetes (322 exposed pregnancies (insulin aspart: 157; human insulin: 165)) did not indicate any adverse effect of insulin aspart on pregnancy or on the health of the foetus/newborn. 
Klinično preskušanje, v katerem so primerjali varnost in učinkovitost insulina aspart in humanega insulina v zdravljenju nosečnic s sladkorno boleznijo tipa 1 (322 izpostavljenih nosečnosti (insulin aspart 157, humani insulin 165)), ni pokazalo nobenih neželenih učinkov insulina aspart na nosečnost ali na zdravje ploda/novorojenčka.
B Check that the insulin in your pen is clear and colourless. 
B Preverite, da je insulin v injekcijskem peresniku bister in brezbarven.
If administration by infusion pump is necessary, a vial or NovoRapid PumpCart should be used. 
Če je potrebno dajanje z infuzijsko črpalko, je treba uporabiti vialo ali zdravilo NovoRapid PumpCart.
If you suspect NovoRapid PumpCart is damaged, take it back to your supplier. 
Če sumite, da je vložek NovoRapid PumpCart poškodovan, ga vrnite v lekarno.
NovoRapid is used to reduce the high blood sugar level in adults, adolescents and children aged 1 year and above with diabetes mellitus (diabetes). 
Zdravilo NovoRapid se uporablja za znižanje visokega krvnega sladkorja pri odraslih, mladostnikih in otrocih, starih 1 leto in več, s sladkorno boleznijo.
If you need more insulin than the units left in your pen, you can split your dose between two pens. 
Če potrebujete več insulina, kot ga je preostalo v injekcijskem peresniku, lahko razdelite odmerek in ga injicirate z dvema injekcijskima peresnikoma.
► If the insulin does not appear clear and colourless. 
► če raztopina insulina ni povsem bistra in brezbarvna.
Fig. I. Blood glucose concentrations following a single pre-meal dose of NovoRapid injected immediately before a meal (solid curve) or soluble human insulin administered 30 minutes before a meal (hatched curve) in patients with type 1 diabetes mellitus. 
Koncentracija glukoze v krvi po enem odmerku zdravila NovoRapid, injiciranem tik pred obrokom (neprekinjena krivulja) in topnega humanega insulina, apliciranega 30 minut pred obrokom (pikčasta krivulja) pri bolnikih s sladkorno boleznijo tipa 1.
Always carry glucose tablets or high sugar snacks with you, just in case. 
Za vsak primer imejte vedno pri sebi tablete glukoze ali prigrizke z visoko vsebnostjo sladkorja.
The relative differences in the pharmacodynamic properties (GIRmax,AUCGIR, 0-120 min) between insulin aspart and soluble human insulin in the elderly were similar to those seen in healthy subjects and in younger patients with diabetes. 
Relativne razlike v farmakodinamičnih lastnostih (GIRmax, AUCGIR, 0-120 min) insulina aspart in topnega humanega insulina so se pri starejših skladale s tistimi, ki so bile ugotovljene pri zdravih preiskovancih in mlajših bolnikih s sladkorno boleznijo.
• NovoRapid PumpCart should be kept out of reach of others, especially children. 
• Zdravilo NovoRapid PumpCart hranite nedosegljivo drugim osebam, še posebno otrokom.
Basal (all-day) insulin requirements: When you use NovoRapid PumpCart in a pump, your insulin will be constantly delivered to cover your basal need for insulin. 
Bazalne potrebe po insulinu (potrebe čez ves dan): Med uporabo zdravila NovoRapid PumpCart v črpalki, bo ta oddajala insulin ves čas in bo tako krila vašo bazalno potrebo po insulinu.
Insulin aspart is equipotent to soluble human insulin on a molar basis. 
Insulin aspart je na molarni osnovi ekvipotenten topnemu humanemu insulinu.
• Always make sure you have a spare NovoRapid PumpCart available. 
• Poskrbite, da boste vedno imeli na voljo rezervni vložek NovoRapid PumpCart.
Due to the faster onset of action, NovoRapid should generally be given immediately before a meal. 
Zaradi hitrejšega začetka delovanja je treba zdravilo NovoRapid praviloma aplicirati tik pred obrokom.
Eat a meal or snack within 10 minutes of the injection to avoid low blood sugar. 
V 10 minutah po injekciji pojejte obrok ali prigrizek, da ne bo prišlo do nizkega krvnega sladkorja.
Moreover NovoRapid can be used for continuous infusion in a pump system. 
Poleg tega je mogoče zdravilo NovoRapid uporabljati za kontinuirano infundiranje v sistemu s črpalko.
Before use of NovoRapid in the pump system, you must have received a comprehensive instruction in the use and information about any actions to be taken in case of illness, too high or too low blood sugar or failure of the pump system. 
Pred uporabo zdravila NovoRapid v sistemu s črpalko morate dobiti izčrpna navodila o uporabi in informacije o tem, kako ukrepati v primeru bolezni, previsokega ali prenizkega krvnega sladkorja ali odpovedi sistema s črpalko.
Never try to put the inner needle cap back on the needle. 
• Nikoli ne poskušajte notranjega pokrovčka igle znova namestiti na iglo.
What NovoRapid PumpCart is and what it is used for What you need to know before you use NovoRapid PumpCart How to use NovoRapid PumpCart Possible side effects 
Kaj je zdravilo NovoRapid PumpCart in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo NovoRapid PumpCart Kako uporabljati zdravilo NovoRapid PumpCart Možni neželeni učinki
Each ml contains 100 units of insulin aspart. 
En ml vsebuje 100 enot insulina aspart.
Make sure you have an alternative delivery method for your insulin available for injection under the skin (for example, a pen injector) in case the pump stops working. 
Poskrbite, da boste vedno imeli na voljo še pripomoček z drugim načinom injiciranja insulina (na primer injekcijski peresnik) za primer, da črpalka neha delovati.
Anaphylactic reactions: 
Anafilaktične reakcije
► Please ask your doctor whether you can drive a car or operate a machine: 
Vpliv na sposobnost upravljanja vozil in strojev ► Prosimo posvetujte se z zdravnikom, ali lahko upravljate vozila in stroje, če:
Renal or hepatic impairment may reduce the patient's insulin requirements. 
Ledvična ali jetrna okvara lahko zmanjša bolnikovo potrebo po insulinu.
Follow your doctor's instructions and advice about the use of NovoRapid PumpCart in the pump. 
Upoštevajte zdravnikova navodila in nasvete o uporabi zdravila NovoRapid PumpCart v črpalki.
• Glucocorticoids (such as ‘cortisone' used to treat inflammation) 
• glukokortikoide (na primer “kortizon”, uporabljajo se za zdravljenje vnetja),
Administration with an insulin delivery system 
Apliciranje s sistemom za dajanje insulina
• After the injection, the needle should remain under the skin for at least 6 seconds to ensure that the full dose has been delivered. 
• Po injiciranju mora igla ostane pod kožo vsaj 6 sekund, da je zanesljivo injiciran celotni odmerek.
Before using NovoRapid PumpCart in a pump, you must have thorough training in the use of the pump and information about any actions to be taken in case of illness, too high or too low blood sugar or failure of the pump. 
Pred uporabo zdravila NovoRapid PumpCart v črpalki morate opraviti temeljito usposabljanje za uporabo črpalke in dobiti navodila o ukrepanju v primeru bolezni, previsokega ali prenizkega krvnega sladkorja ali odpovedi črpalke.
A consequence of the pharmacodynamics of rapid-acting insulin analogues is that if hypoglycaemia occurs, it may occur earlier after an injection when compared with soluble human insulin. 
Posledica farmakodinamike hitrodelujočih insulinskih analogov je, da se hipoglikemija - če do nje pride - lahko pojavi v krajšem času po injiciranju kot pri topnem humanem insulinu.
Needles, syringes, cartridges, pre-filled pens and infusion sets must not be shared. 
Igel, injekcijskih brizg, vložkov, napolnjenih injekcijskih peresnikov in kompletov za infundiranje se ne sme deliti z drugimi.
Follow the pump manual (user guide). 
Upoštevajte navodila za uporabo črpalke (vodnik za uporabnika).
When you are using an insulin pump 
Ko uporabljate insulinsko črpalko
Insulin mixtures should not be administered intravenously or used with a subcutaneous insulin infusion pump. 
Mešanic insulinov se ne sme dajati intravensko ali jih uporabiti z insulinskimi črpalkami za subkutano infundiranje.
Clinical trials in patients with type 1 diabetes have demonstrated a reduced risk of nocturnal hypoglycaemia with insulin aspart compared with soluble human insulin. 
Klinična preskušanja pri bolnikih s sladkorno boleznijo tipa 1 so pokazala, da je tveganje za nočne hipoglikemije z insulinom aspart manjše kot s topnim humanim insulinom.
• Always carry an extra pen and new needles with you, in case of loss or damage. 
• Vedno nosite s seboj rezervni injekcijski peresnik in nove igle, če jih izgubite ali se poškodujejo.
F Turn the dose selector to select 2 units. 
F Zavrtite izbirnik odmerka tako, da boste izbrali 2 enoti.
The dose selector clicks differently when turned forwards, backwards or past the number of units left. 
Izbirnik odmerka pri vrtenju klika drugače, če vrtite naprej, nazaj ali če želite izbrati večji odmerek, kot je število preostalih enot insulina.
Inject the air into the vial containing the NPH insulin and pull out the needle. 
Injicirajte zrak v vialo z insulinom NPH in potegnite iglo iz nje.
The maximum effect is exerted between 1 and 3 hours after the injection. 
Največji učinek doseže od 1 do 3 ure po injekciji.
Rare side effects May affect less than 1 in 1,000 people. 
Redki neželeni učinki Pojavijo se lahko pri manj kot 1 bolniku od 1.000 bolnikov.
H Turn the dose selector to select the number of units you need to inject. 
Zavrtite izbirnik odmerka, da boste izbrali število enot, ki jih morate injicirati.
Dispose of it carefully, and put the pen cap back on after every use. 
Pazljivo jo zavrzite in na injekcijski peresnik po vsaki uporabi znova namestite njegov pokrovček.
When used with an insulin infusion pump, NovoRapid should not be mixed with any other insulin medicinal products. 
Kadar se zdravilo NovoRapid uporablja v insulinski infuzijski črpalki, se ga ne sme mešati z nobenim drugim insulinskim zdravilom.
• Check the label to make sure that it is NovoRapid PumpCart. 
• Preverite nalepko in se tako prepričajte, da boste uporabili zdravilo NovoRapid PumpCart.
What NovoRapid PumpCart is and what it is used for 
Kaj je zdravilo NovoRapid PumpCart in za kaj ga uporabljamo
If it is dropped, damaged or crushed, there is a risk of insulin leakage. 
Če pade, se poškoduje ali z njim kam udarite, obstaja nevarnost za puščanje insulina.
NovoRapid can only be mixed with NPH (Neutral Protamine Hagedorn) insulin in a syringe for subcutaneous use. 
Zdravilo NovoRapid se sme mešati samo z insulinom NPH (nevtralni protamin Hagedorn) v injekcijski brizgi za subkutano uporabo.
► Always use a new needle for each injection to prevent contamination. 
► Za vsako injiciranje vedno uporabite novo iglo, da preprečite kontaminacijo.
When NovoRapid is mixed with NPH insulin, NovoRapid should be drawn into the syringe first, and the mixture should be injected immediately after mixing. 
Kadar se zdravilo NovoRapid meša z insulinom NPH, je treba v injekcijsko brizgo najprej potegniti zdravilo NovoRapid in mešanico injicirati takoj po pripravi.
Some patients with long-standing type 2 diabetes and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure. 
Pri nekaterih bolnikih z dolgotrajno sladkorno boleznijo tipa 2 in boleznijo srca ali predhodno možgansko kapjo, ki so se zdravili s pioglitazonom in insulinom, je prišlo do razvoja srčnega popuščanja.
Please also read the pump manual (user guide) that comes with your insulin pump. 
Preberite tudi navodila za uporabo črpalke (vodnik za uporabnika), ki so priložena insulinski črpalki.
It may affect less than 1 in 10,000 people. 
Pojavi se lahko pri manj kot 1 od 10.000 bolnikov.
Close glucose monitoring is recommended during the transfer and in the initial weeks thereafter (see section 4.4). 
Med prehodom in v prvih tednih po prehodu je priporočljivo skrbno spremljanje glukoze v krvi (glejte poglavje 4.4).
• NovoRapid PumpCart contains 1.6 ml insulin aspart solution, equivalent to 160 units. 
• Vložek NovoRapid PumpCart vsebuje 1,6 ml raztopine insulina aspart, kar ustreza 160 enotam.
1 vial of 10 ml. 
1 viala z 10 ml.
Beta-blockers may mask the symptoms of hypoglycaemia. 
Antagonisti adrenergičnih receptorjev beta lahko prikrijejo simptome hipoglikemije.
In rare cases, the presence of such insulin antibodies may necessitate adjustment of the insulin dose in order to correct a tendency to hyper- or hypoglycaemia. 
V redkih primerih je zaradi nastanka protiteles proti insulinu bolniku potrebno prilagoditi odmerek, da se prepreči nagnjenje k hiper- ali hipoglikemiji.
They may include cold sweats, cool pale skin, fatigue, nervousness or tremor, anxiousness, unusual tiredness or weakness, confusion, difficulty in concentration, drowsiness, excessive hunger, vision changes, headache, nausea and palpitation. 
Obsegajo lahko hladno znojenje, hladno bledo kožo, utrujenost, živčnost ali tremor, tesnobnost, nenavadno izčrpanost ali šibkost, zmedenost, težave s koncentracijo, zaspanost, čezmerno lakoto, motnje vida, glavobol, navzeo in palpitacije.
Draw into the syringe the same amount of air as the dose of NovoRapid. 
Potegnite v brizgo enako količino zraka, kot je odmerek zdravila NovoRapid.
What NovoRapid looks like and contents of the pack NovoRapid is presented as a solution for injection. 
Izgled zdravila NovoRapid in vsebina pakiranja Zdravilo NovoRapid je na voljo v obliki raztopine za injiciranje.